Radnor Capital Management’s ResMed RMD Stock Holding History

Radnor Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$721K	Hold	3,700	–	–	0.1%	197
2026 Q1	$831K	Hold	3,700	–	–	0.12%	178
2025 Q4	$891K	Hold	3,700	–	–	0.13%	166
2025 Q3	$1.01M	Hold	3,700	–	–	0.15%	153
2025 Q2	$955K	Hold	3,700	–	–	0.15%	162
2025 Q1	$828K	Hold	3,700	–	–	0.14%	173
2024 Q4	$846K	Hold	3,700	–	–	0.14%	172
2024 Q3	$903K	Buy	+3,700	New	+$827K	0.13%	177
2024 Q2	–	Sell	-3,700	Closed	-$733K	–	274
2024 Q1	$733K	Hold	3,700	–	–	0.13%	185
2023 Q4	$636K	Hold	3,700	–	–	0.12%	185
2023 Q3	$547K	Buy	+3,700	New	+$669K	0.11%	197

Other funds holding RMD

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

DJSG

D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Radnor Capital Management's RMD Position: Q2 2026 in Review

Radnor Capital Management held its ResMed (RMD) position steady in Q2 2026 at 3,700 shares worth $721K. The position accounts for 0.1% of the portfolio, ranked #197.

Radnor Capital Management first reported a position in RMD in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.01M in Q3 2025. 141 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Radnor Capital Management held 3,700 shares of ResMed worth $721K as of Q2 2026.
Radnor Capital Management left its ResMed share count unchanged in Q2 2026.
ResMed made up 0.1% of Radnor Capital Management's portfolio in Q2 2026, its #197 holding.
Radnor Capital Management first reported a position in ResMed in Q3 2023 and has held it in 11 quarters since.
Radnor Capital Management's ResMed position peaked at $1.01M in Q3 2025.
141 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Radnor Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.